Please use this identifier to cite or link to this item:
Title: Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies
Authors: Martins, SF
Reis, RM
Rodrigues, AM
Baltazar, F
Filho, AL
Keywords: Neoplasias Colorrectais
Factor de Crescimento Endotelial Vascular
Inibidores da Angiogénese
Issue Date: 2011
Abstract: Colorectal cancer (CRC) is one of the cancer models and most of the carcinogenic steps are presently well understood. Therefore, successful preventive measures are currently used in medical practice. However, CRC is still an important public health problem as it is the third most common cancer and the fourth most frequent cause of cancer death worldwide. Nowadays, pathologic stage is a unique and well-recognized prognostic indicator, however, more accurate indicators of the biologic behavior of CRC are expected to improve the specificity of medical treatment. Angiogenesis plays an important role in the growth and progression of cancer but its role as a prognostic factor is still controversial. Probably the most important clinical implication of tumor angiogenesis is the development of anti-angiogenic therapy. The goal of this review is to critically evaluate the role of angiogenic markers, assessed by either endoglin-related microvessel density or expression of vascular endothelial growth factor family members in the CRC setting and discuss the role of these angiogenic markers in anti-angiogenic therapie
Peer review: yes
Appears in Collections:HB - GAS - Artigos

Files in This Item:
File Description SizeFormat 
Role of endoglin and VEGF family expression in colorectal cancer (1).pdf760,98 kBAdobe PDFView/Open

FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.